StockAnalyzer

Financial Analysis

DashboardSectorsComparablesScreenerUniverseMicrocapsAI 2nd OrderTheme MapEnergy & MaterialsMacroWatchlistCompareMi CarteraPortfolio

Recent

v0.1
NUC.AX$0.13-13.33%
Fair $0.13+0.0%

NUC.AX

Nuchev Limited

Consumer Defensive / Packaged FoodsASX

$0.13

-0.02 (-13.33%)

Fairly Valued+0.0%Fair Value $0.13Fund rank 30/100 · Data gapFallback financials|
SA 26/D
F-Score: 4/9
Low Profitability

FCF base 3Y

n/d

n/d CAGR · yield n/d

FCF base 5Y

n/d

n/d base · n/d expected

Precio de entrada

n/d

MOS 33% · confianza 23%

FCF escenarios

weak_data · normalized FCF $-3.7M · quality 66.0/100

Data gap 30/100
Bear 5Yn/dn/d
Base 5Yn/dn/d
Bull 5Yn/dn/d
Return 0/100Downside 20/100Model quality 30/100Data QA 20/100

Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.

Quality + valuation scorecard

SA Score

26/100

D

Piotroski

4/9

balance/quality

Valuation

50/100

+0.0% upside

5Y CAGR

+0.0%

50/100

Data QA

16/100

SEC 0%

Latest source: unknownPeriods: 4Warnings: 1unknown: 4
No SEC-backed annual rows; valuation uses fallback financial data. Insufficient audited annual history (<3 SEC-backed years); composite fair value and forward targets are disabled until manually verified. ROE is -34.0%, below the 5% threshold
Thesis & Journal · NUC.AXLocal privado en este navegador · Nuchev Limited
Plantilla tipo buy-side: tesis, bull/base/bear, catalizadores, riesgos, kill criteria y fecha de revisión. Esto no gasta GPT-5.5; luego lo usamos como contexto del memo.

Sin guardar todavía.

Market Cap

$20M

P/E

N/A

•

EV/EBITDA

N/A

•

ROE

-34.0%

↓

Gross Margin

47.3%

↑

Debt/Equity

0.03

↓
52-Week Range$0
$0$0

TradingView lightweight chart

NUC.AX price, volumen y niveles de valoración

Último $0.130Periodo -95.6%
Fair value: $0.130

Price & Ratios

Absolute Values (Left Axis)

Ratios / Percentages (Right Axis)

Financial statement dashboard

Crecimiento, márgenes y provenance

2022–2025 · 3 años de histórico normalizado

Revenue CAGR

+33.1%

FCF CAGR

—

FCF margin

-17.3%

FCF / Net income

1.04x

Latest source

Provider fallback

Margin decomposition

Último año: revenue $22.9M · net income $-3.8M · FCF $-4.0M

2022-FY → 2025-FY

Gross margin

47.3%+18.8% pts

Operating margin

-18.3%+91.5% pts

Net margin

-16.7%+97.6% pts

FCF margin

-17.3%+68.2% pts
MetricTTM
2025
2024
2023
2022
Income Statement
Revenue$22.9M$22.9M$11.3M$8.8M$9.7M
Net Income$-3.8M$-3.8M$-7.3M$-8.8M$-11.1M
EBITDA$-3.1M$-3.1M$-7.2M$-8.5M$-10.9M
EPS-0.03-0.03-0.09-0.17-0.20
Gross Margin47.3%47.3%32.0%18.8%28.6%
Operating Margin-18.3%-18.3%-65.4%-95.7%-109.8%
Net Margin-16.7%-16.7%-64.5%-100.2%-114.2%
Balance Sheet
Debt/Equity0.030.030.020.020.01
Current Ratio2.152.15———
Cash Flow
Free Cash Flow$-4.0M$-4.0M$-3.7M$-3.4M$-8.3M
Returns
ROE-34.0%-34.0%-49.6%-68.7%-70.2%
Valuation
P/B1.691.690.930.810.79
Growth & Yield
Revenue Growth102.2%102.2%29.0%-9.6%—
EPS Growth69.5%69.5%49.7%13.5%—

Revenue, Net Income & Free Cash Flow ($B)

Margins (%)

Returns (%)

Leverage & Liquidity

Reverse DCF · market-implied EPS growthterminal P/E 15.0x · COE 10.0%
Reverse DCF requires positive EPS; loss-making or zero-EPS companies cannot produce a clean EPS hurdle.

Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.

Return attribution · 1Y approxreconcilia total -18.8%

Total return

-18.8%

Start / end P/E

n/dx → n/dx

EPS bridge

-0.09 → -0.03

Residual

-18.8%

EPS growthn/d
Multiple reratingn/d
Dividend+0.0%
Residual / FX / buybacks / cross-term-18.8%

EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.

Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.